limit tamoxifen use to 5 years
January 1996
The National Cancer Institute is now alerting oncologists to limit tamoxifen use to 5 years...for certain women being treated for early-stage breast cancer.
Taking tamoxifen for 5 years after lumpectomy or mastectomy significantly reduces the risk of recurrence and improves survival.
New evidence says that LONGER use doesn't further improve survival. It might even be detrimental...by increasing uterine cancer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive